Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
61 Leser
Artikel bewerten:
(0)

Vaccines and Influenza Drugs Market to Grow 10.24% CAGR by 2022 Says a new Research at ReportsnReports

PUNE, India, July 20, 2017 /PRNewswire/ --

Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) report has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.

Browse 78 Tables and Figures, 10 Companies Profiles, spread across 164 pages @ http://www.reportsnreports.com/reports/1010794-global-influenza-drugs-and-vaccines-market-by-drugs-zanamivir-oseltamivir-phosphate-peramivir-by-vaccine-trivalent-quadrivalent-analysis-by-region-by-country-opportunities-and-forecast-2016-2021-ia-japan.html.

Global Influenza Drugs and Vaccines Market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 - 2022, chiefly driven by increasing spending over various immunization programmes. Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.

Company Profile Analysis covered in this Report - Falvogen, Gilead Science and Bio Cryst, GlaxoSmithKline, Sanofi Pasteur, Inc., CSL Limited, Astrazeneca, Protein Sciences Corporation, Serum Institute of India Pvt. Ltd., Emergent Biosolutions, Emergent Biosolutions, BioCryst Pharmaceuticals.Inc., and Alvogen. Order a copy of Report @ http://www.reportsnreports.com/purchase.aspx?name=1010794.

Scope of the Report: Global Influenza Market; Regional Markets - North America, Europe, APAC, RoW; Country Analysis - US, Canada, UK, Germany, France, Japan, China, India;

(Actual Period: 2012-2016E, Forecast Period: 2017-2022)
By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
By Vaccine Type: Trivalent, Quadrivalent
By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir

Table of Contents

Influenza Market: An Introduction
Global Influenza Market Overview
Global Influenza Market: Product Analysis
Global Influenza Vaccines & Drugs - Pipeline Analysis
Global Influenza Market, Breakdown By Region

Other related report Global Lysine Market by Manufacturers, Countries, Type and Application, Forecast to 2022 is a professional and in-depth study on the current state of the Lysine industry. TheLysine market analysis is provided for the international market including development history, competitive landscape analysis, and major regions development status. Report provides Introduction, product scope, market overview, market opportunities, market risk, and market driving force. This report focuses on the Lysine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. This report covers market segment by manufacturers: CJ(KR), Ajinomoto(JP), ADM(US), Evonik(DE), GLOBAL Bio-Chem(CN), Meihua(CN), COFCO(CN), East Hope(CN), Juneng Golden Corn(CN), and Chengfu Group(CN).

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001
Maharashtra,India.
+1-8883915441
sales@reportsandreports.com

Connect With Us On:

RSS Link:http://www.reportsnreports.com/feed/p-210-azoth-analytics.xml

LinkedIn: http://www.linkedin.com/company/reportsnreports


© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.